Cell-Based Therapy for Neural Disorders - Anticipating Challenges

被引:34
|
作者
Chiu, Arlene Y. [1 ]
Rao, Mahendra S. [2 ]
机构
[1] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA USA
[2] Life Technol Corp, Carlsbad, CA USA
关键词
Pluripotent stem cells; ESC; CNS roadblocks; EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; DIRECT CONVERSION; FIBROBLASTS; PLASTICITY; MUTATION; NEURONS; INJURY; CNS;
D O I
10.1007/s13311-011-0066-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurological syndromes, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, amyotrophic lateral sclerosis, and lysosomal storage disorders, such as Battens disease, are devastating because they result in increasing loss of cognitive and physical function. Sadly, no drugs are currently available to halt their progression. The relative paucity of curative approaches for these and other conditions of the nervous system have led to a widespread evaluation of alternative treatment modalities including cell-based interventions. Several cell types have been tested successfully in animal models where safety and efficacy have been demonstrated. Early clinical trials have also been initiated in humans, and some have shown a degree of success albeit on a more limited scale than in animal experiments. Recent demonstrations that pluripotent stem cells, such as embryonic stem cells and induced pluripotent stem cells, can differentiate into a variety of specific neural phenotypes has stimulated worldwide enthusiasm for developing cell-based intervention of neurological disease. Indeed, several groups are preparing investigational new drug applications to treat disorders as diverse as macular degeneration, lysosomal storage diseases, and Parkinson's disease. It is noteworthy that cell replacement therapies for neurological conditions face key challenges, some of which are unique, because of the development and organization of the nervous system, its metabolism, and connectivity. Choice of the cell (or cells), the process of manufacturing them, defining the delivery pathway, developing and testing in an appropriate preclinical model, selecting a patient population, and visualizing and following or monitoring patients all pose specific issues as related to the central and peripheral nervous systems. In this review, we address a myriad of challenges that are solvable, but require careful planning and attention to the special demands of the human nervous system.
引用
收藏
页码:744 / 752
页数:9
相关论文
共 50 条
  • [1] Cell-Based Therapy for Neural Disorders — Anticipating Challenges
    Arlene Y. Chiu
    Mahendra S. Rao
    Neurotherapeutics, 2011, 8 : 744 - 752
  • [2] Cell-based Therapy for Hypertension: Challenges and Perspectives
    Gasparotto Junior, Arquimedes
    dos Reis Livero, Francislaine Aparecida
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (26) : 3084 - 3089
  • [3] Progress and challenges in the development of a cell-based therapy for hemophilia A
    Fomin, M. E.
    Togarrati, P. P.
    Muench, M. O.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (12) : 1954 - 1965
  • [4] The challenges and optimization of cell-based therapy for cardiovascular disease
    Xu, Shiyue
    Qiu, Yumin
    Tao, Jun
    JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2021, 9 (04) : 234 - 238
  • [5] Cell-based therapy technology classifications and translational challenges
    Mount, Natalie M.
    Ward, Stephen J.
    Kefalas, Panos
    Hyllner, Johan
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2015, 370 (1680)
  • [6] Cell-based Therapy for Ocular Disorders: A Promising Frontier
    Ahani-Nahayati, Milad
    Niazi, Vahid
    Moradi, Alireza
    Pourjabbar, Bahareh
    Roozafzoon, Reza
    Baradaran-Rafii, Alireza
    Keshel, Saeed Heidari
    CURRENT STEM CELL RESEARCH & THERAPY, 2022, 17 (02) : 147 - 165
  • [7] Neural Stem Cell-Based Therapy for Ischemic Stroke
    Kokaia, Zaal
    Darsalia, Vladimer
    TRANSLATIONAL STROKE RESEARCH, 2011, 2 (03) : 272 - 278
  • [8] Neural stem cells for diabetes cell-based therapy
    Basak, Onur
    Clevers, Hans
    EMBO MOLECULAR MEDICINE, 2011, 3 (12) : 698 - 700
  • [9] Neural Stem Cell-Based Therapy for Ischemic Stroke
    Zaal Kokaia
    Vladimer Darsalia
    Translational Stroke Research, 2011, 2 : 272 - 278
  • [10] Pluripotent Stem Cell-Based Cell Therapy- Promise and Challenges
    Yamanaka, Shinya
    CELL STEM CELL, 2020, 27 (04) : 523 - 531